To date, several cases of compound heterozygous or homozygous SCN4A variants, exhibiting null and/or loss-of-function, have been reported in congenital myopathy, congenital myasthenic syndrome, or fetal dyskinesia [8, 10, 13, 14, 16]. This evidence concerns the gene SCN4A and congenital myasthenic syndrome.